Trial Outcomes & Findings for Extending HIV Care Beyond the Rural Health Center (NCT NCT00371540)

NCT ID: NCT00371540

Last Updated: 2016-12-20

Results Overview

Number of Subjects Lost to follow-up

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

208 participants

Primary outcome timeframe

12 months

Results posted on

2016-12-20

Participant Flow

Participant milestones

Participant milestones
Measure
I Routine Care
Routine care in the clinic
II Home Visits
Follow-up in clinic every 3 months, home visits monthly Home visit by community care coordinators: Decrease in patient visits to the clinic from the standard of once per month to every 3 months with home visits monthly.
Overall Study
STARTED
112
96
Overall Study
COMPLETED
102
87
Overall Study
NOT COMPLETED
10
9

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Extending HIV Care Beyond the Rural Health Center

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
I Routine Care
n=112 Participants
Routine care in the clinic
II Home Visits
n=96 Participants
Follow-up in clinic every 3 months, home visits monthly Home visit by community care coordinators: Decrease in patient visits to the clinic from the standard of once per month to every 3 months with home visits monthly.
Total
n=208 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
112 Participants
n=5 Participants
96 Participants
n=7 Participants
208 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Gender
Female
81 Participants
n=5 Participants
71 Participants
n=7 Participants
152 Participants
n=5 Participants
Gender
Male
31 Participants
n=5 Participants
25 Participants
n=7 Participants
56 Participants
n=5 Participants
Region of Enrollment
Kenya
112 participants
n=5 Participants
96 participants
n=7 Participants
208 participants
n=5 Participants

PRIMARY outcome

Timeframe: 12 months

Number of Subjects Lost to follow-up

Outcome measures

Outcome measures
Measure
I Rountine Care
n=112 Participants
II Home Visits
n=96 Participants
Lost to Follow-up
5 participants
5 participants

SECONDARY outcome

Timeframe: 12 months

Detectable VL at 12 months

Outcome measures

Outcome measures
Measure
I Rountine Care
n=96 Participants
II Home Visits
n=86 Participants
Viral Load
13 participants
9 participants

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome measures
Measure
I Rountine Care
n=112 Participants
II Home Visits
n=96 Participants
Death
0 participants
1 participants

Adverse Events

I Rountine Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

II Home Visits

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
I Rountine Care
n=112 participants at risk
II Home Visits
n=96 participants at risk
Injury, poisoning and procedural complications
Death
0.00%
0/112
1.0%
1/96 • Number of events 1

Other adverse events

Adverse event data not reported

Additional Information

Kara Wools-Kaloustian

Indiana University School of Medicine

Phone: 317-274-7936

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place